How to Help Your Patients Save Money on Natesto: A Provider's Guide to Savings Programs

Natesto is a clinically valuable testosterone replacement option — particularly for patients who require low transfer risk or wish to preserve fertility. But at an average retail price of approximately $1,047 per monthly supply, cost is one of the top reasons patients discontinue or switch to other formulations. This guide is designed to help prescribers understand all available cost-reduction tools for Natesto and incorporate them into their patient counseling workflow.

Why Natesto Cost Management Matters Clinically

When patients cannot afford a medication, they stop taking it — often without telling their provider. For testosterone replacement therapy, treatment interruption leads to a return of hypogonadism symptoms: fatigue, decreased libido, erectile dysfunction, and mood changes. By proactively addressing cost at the time of prescribing, clinicians can meaningfully improve treatment adherence and patient outcomes.

Overview of Natesto Pricing

Here is a summary of what patients can expect to pay for Natesto in 2026:

Average retail price: ~$1,047 for a 30-day supply (3 dispensers)

With Natesto Savings Card (commercially insured): As low as $0/month (up to $3,500 annual savings)

With Natesto Cash Option Program (uninsured/not covered): $140 per prescription (up to 30-day supply)

With GoodRx coupon: Approximately $165 at participating pharmacies

No generic available: Natesto remains brand-name only as of 2026

Program 1 — Natesto Savings Card (Commercially Insured Patients)

The Natesto Savings Card is the most impactful cost-reduction tool for most commercially insured patients. Eligible patients may pay as little as $0 per month for their Natesto prescription, with total annual savings of up to $3,500.

Clinical workflow integration tips:

Include the Natesto Savings Card enrollment information with every new Natesto prescription (printed instructions or a pharmacy handout).

Instruct your medical assistant or front desk to counsel patients on the savings program at the time of prescribing.

Provide the manufacturer contact number: 1-833-817-8688.

Key restrictions to communicate to patients:

Not available to Medicare or Medicaid patients.

Annual benefit cap of $3,500 applies.

Dispensed quantities must be no less than 20 days (2 dispensers) and no more than 90 days (9 dispensers) per prescription.

Program 2 — Natesto Cash Option Program (Uninsured Patients)

For patients without insurance or whose insurance does not cover Natesto, the Cash Option Program from Acerus Pharmaceuticals provides a fixed cash price of $140 per prescription for up to 30 days of supply (3 dispensers). This program is available for up to 12 refills. Eligibility: patients 18 years or older without active government insurance coverage.

Program 3 — GoodRx and Prescription Discount Cards

For patients who do not qualify for the manufacturer programs, GoodRx can bring the price of Natesto to approximately $165. The GoodRx coupon is used instead of insurance and cannot be combined with the Natesto Savings Card. Other discount services (SingleCare, RxSaver) may also have competitive pricing at certain pharmacies.

Insurance Coverage Strategy: Prior Authorization

For commercially insured patients, pursuing prior authorization can result in insurance coverage that further reduces the patient's out-of-pocket cost — even lower than the manufacturer savings card alone (e.g., $0 with a high-deductible plan plus Savings Card stacking, where permitted).

Key elements of a successful prior authorization for Natesto:

Diagnosis: primary hypogonadism or hypogonadotropic hypogonadism, ICD-10 codes E29.1 or E23.0

Lab documentation: two fasting morning serum total testosterone values below 300 ng/dL on separate days

Rationale for intranasal route: fertility preservation concern, skin conditions, occupational exposure risk to household members, inadequate response or intolerance to alternatives

Nasal anatomy clearance: no contraindicated nasal conditions present

When to Consider a Cost-Driven Formulation Switch

If a patient has exhausted manufacturer savings programs and cannot obtain insurance coverage, and cost remains prohibitive, a formulation change may be appropriate. Generic testosterone cypionate injection (~$20–$60/month) and generic testosterone topical gel (~$41–$80/month with coupons) are effective alternatives with established efficacy and broad insurance coverage.

Frame this clinically: "We have several options that treat the same condition as Natesto. Let's find the one that fits your situation best so you can stay on therapy consistently." Consistent treatment is more important than the specific formulation.

Helping Patients Find Natesto at a Pharmacy

Even patients who have savings programs may struggle to find a pharmacy with Natesto in stock. Recommend medfinder — a paid service that calls pharmacies in the patient's area to identify which ones have Natesto available. This reduces the access barrier that often causes patients to give up and discontinue therapy before cost solutions are even reached.

For a full overview of availability challenges and how to guide patients through them, see our provider guide to helping patients find Natesto in stock.